Successful and Rapid Reduction in Neurosedative and Analgesic Medications in Complex Infants with Severe Bronchopulmonary Dysplasia after Tracheostomy Placement: Experience with 24-hour Propofol Infusions

Kathleen E. Hannan,Stephanie L. Bourque,Emma Ross,Erica M. Wymore,John P. Kinsella,Erica W. Mandell,Satya S. Houin
DOI: https://doi.org/10.1016/j.jpeds.2024.114040
IF: 6.314
2024-03-30
The Journal of Pediatrics
Abstract:Infants with severe bronchopulmonary dysplasia may require high doses of neurosedative medications to ensure pain control and stability following tracheostomy placement. Subsequent weaning of these medications safely and rapidly is a challenge. We describe a 24-hour propofol infusion to reduce neurosedative medications in 3 high-risk infants following tracheostomy placement.
pediatrics
What problem does this paper attempt to address?